ZA200307475B - Carbamate compounds for use in the treatment of pain. - Google Patents

Carbamate compounds for use in the treatment of pain.

Info

Publication number
ZA200307475B
ZA200307475B ZA200307475A ZA200307475A ZA200307475B ZA 200307475 B ZA200307475 B ZA 200307475B ZA 200307475 A ZA200307475 A ZA 200307475A ZA 200307475 A ZA200307475 A ZA 200307475A ZA 200307475 B ZA200307475 B ZA 200307475B
Authority
ZA
South Africa
Prior art keywords
pain
treatment
carbamate compounds
carbamate
compounds
Prior art date
Application number
ZA200307475A
Other languages
English (en)
Inventor
Carlos R Plata-Salaman
Roy E Twyman
Boyu Zhao
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of ZA200307475B publication Critical patent/ZA200307475B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/325Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA200307475A 2001-02-27 2003-09-25 Carbamate compounds for use in the treatment of pain. ZA200307475B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27188801P 2001-02-27 2001-02-27

Publications (1)

Publication Number Publication Date
ZA200307475B true ZA200307475B (en) 2005-01-03

Family

ID=23037511

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200307475A ZA200307475B (en) 2001-02-27 2003-09-25 Carbamate compounds for use in the treatment of pain.

Country Status (28)

Country Link
US (1) US6815464B2 (ru)
EP (1) EP1404312B1 (ru)
JP (1) JP4276838B2 (ru)
KR (1) KR100906315B1 (ru)
CN (1) CN1849116A (ru)
AR (1) AR033427A1 (ru)
AT (1) ATE493125T1 (ru)
AU (1) AU2002254015B2 (ru)
BR (1) BR0207673A (ru)
CA (1) CA2439274C (ru)
CY (1) CY1111349T1 (ru)
CZ (1) CZ20032298A3 (ru)
DE (1) DE60238765D1 (ru)
DK (1) DK1404312T3 (ru)
ES (1) ES2356617T3 (ru)
HU (1) HUP0303236A3 (ru)
IL (1) IL157593A0 (ru)
MX (1) MXPA03007721A (ru)
MY (1) MY129312A (ru)
NO (1) NO20033804L (ru)
NZ (1) NZ527994A (ru)
PL (1) PL364647A1 (ru)
PT (1) PT1404312E (ru)
RS (1) RS67603A (ru)
RU (1) RU2283106C2 (ru)
TW (1) TWI304735B (ru)
WO (1) WO2002067922A1 (ru)
ZA (1) ZA200307475B (ru)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2454049A1 (en) * 2001-07-16 2003-01-30 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating neuropathic pain
MX2008012092A (es) * 2006-03-24 2008-10-03 Wyeth Corp Tratamiento del dolor.
WO2010071865A1 (en) 2008-12-19 2010-06-24 Nuon Therapeutics, Inc. Pharmaceutical compositions and methods for treating hyperuricemia and related disorders
US20100160351A1 (en) * 2008-12-19 2010-06-24 Nuon Therapeutics, Inc. Pharmaceutical compositions and methods for treating hyperuricemia and related disorders
WO2011032175A1 (en) 2009-09-14 2011-03-17 Nuon Therapeutics, Inc. Combination formulations of tranilast and allopurinol and methods related thereto
WO2011055944A2 (en) * 2009-11-06 2011-05-12 Sk Holdings Co., Ltd. Methods for treating fibromyalgia syndrome
PL2496228T3 (pl) 2009-11-06 2014-06-30 Sk Biopharmaceuticals Co Ltd Sposoby leczenia zespołu nadpobudliwości psychoruchowej/deficytu uwagi
US8623913B2 (en) 2010-06-30 2014-01-07 Sk Biopharmaceuticals Co., Ltd. Methods for treating restless legs syndrome
US9610274B2 (en) 2010-06-30 2017-04-04 Sk Biopharmaceuticals Co., Ltd. Methods for treating bipolar disorder
US9018253B2 (en) 2010-07-02 2015-04-28 Bio-Pharm Solutions Co., Ltd. Phenylcarbamate compound and muscle relaxant containing the same
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
CN102266317A (zh) * 2011-06-24 2011-12-07 中国人民解放军第三军医大学 丙戊酸及其衍生物的应用
RU2632659C2 (ru) 2011-12-27 2017-10-09 Байо-Фарм Солюшнс Ко., Лтд. Фенилкарбаматные соединения для применения в предупреждении или лечении эпилепсии
KR101717872B1 (ko) 2013-03-12 2017-03-17 (주)바이오팜솔루션즈 소아 간질 및 간질-관련 증후군의 예방 또는 치료용 페닐카바메이트 화합물
KR102421013B1 (ko) * 2016-05-19 2022-07-14 에스케이바이오팜 주식회사 삼차신경통을 예방 또는 치료하기 위한 카바메이트 화합물의 용도

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3278380A (en) 1962-02-06 1966-10-11 Armour Pharma Methods of calming employing diphenyl hydroxy carbamate compounds
US3265728A (en) 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
US5698588A (en) * 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol
GB2340074A (en) * 1998-08-01 2000-02-16 Max Imaging Systems Limited Printing process
EP1305082B1 (en) 2000-07-21 2004-05-26 Ortho-McNeil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain

Also Published As

Publication number Publication date
WO2002067922A1 (en) 2002-09-06
RS67603A (en) 2007-02-05
EP1404312A1 (en) 2004-04-07
NO20033804L (no) 2003-09-30
HUP0303236A3 (en) 2012-07-30
NO20033804D0 (no) 2003-08-26
BR0207673A (pt) 2004-12-28
CA2439274A1 (en) 2002-09-06
MY129312A (en) 2007-03-30
NZ527994A (en) 2005-11-25
PL364647A1 (en) 2004-12-13
JP4276838B2 (ja) 2009-06-10
RU2283106C2 (ru) 2006-09-10
ES2356617T3 (es) 2011-04-11
KR100906315B1 (ko) 2009-07-07
RU2003128984A (ru) 2005-03-20
KR20030076711A (ko) 2003-09-26
EP1404312B1 (en) 2010-12-29
CZ20032298A3 (cs) 2004-08-18
CA2439274C (en) 2011-04-05
CY1111349T1 (el) 2015-08-05
DK1404312T3 (da) 2011-03-14
JP2004523553A (ja) 2004-08-05
MXPA03007721A (es) 2004-11-12
DE60238765D1 (de) 2011-02-10
AU2002254015B2 (en) 2006-08-24
AR033427A1 (es) 2003-12-17
CN1849116A (zh) 2006-10-18
PT1404312E (pt) 2011-02-01
US20020156127A1 (en) 2002-10-24
HUP0303236A2 (hu) 2004-01-28
TWI304735B (en) 2009-01-01
US6815464B2 (en) 2004-11-09
IL157593A0 (en) 2004-03-28
ATE493125T1 (de) 2011-01-15

Similar Documents

Publication Publication Date Title
IL196301A0 (en) Medicament for the treatment of hapatitis c
IL159344A0 (en) Quinuclidines-substituted-multicyclic-heteroaryls for the treatment of disease
AP2004003002A0 (en) azabicyclic-substituted fused-heteroaryl compoundsfor the treatment of disease.
HK1061212A1 (en) Pyranoindazoles and their use for the treatment ofglaucoma
HK1051690A1 (en) Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamidederivatives for the treatment of pain.
HUS2200036I1 (hu) Dihidroimidazolonok alkalmazása kutyák kezelésére
ZA200501288B (en) Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma.
IL157592A0 (en) Carbamate compounds for use in preventing or treating movement disorders
ZA200307475B (en) Carbamate compounds for use in the treatment of pain.
GB0108671D0 (en) Skin treatment
GB0213869D0 (en) The treatment of pain
HK1051692A1 (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain.
IL151765A0 (en) Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
AU2003255843A1 (en) 1,3-thiazolin-4-ones as therapeutic compounds in the treatment of pain
IL164951A0 (en) The treatment of pain with lfendropil
GB0109514D0 (en) Liquid treatment
GB0211297D0 (en) Pain treatment
GB0325957D0 (en) The treatment of pain
GB0216978D0 (en) The treatment of pain
GB0115489D0 (en) Pain treatment
GB0119173D0 (en) Pain treatment
GB0130694D0 (en) Treatment
GB0322014D0 (en) The treatment of pain
GB0108564D0 (en) Skin treatment
ZA200308844B (en) Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease.